Literature DB >> 3668456

Relation between cigarette smoking and use of hormonal replacement therapy for menopausal symptoms.

G Greenberg1, S G Thompson, T W Meade.   

Abstract

The aim of this study was to characterise new users of hormonal replacement therapy (HRT) for the relief of menopausal symptoms and to compare these women with never-users of HRT; 402 new users and 804 never-users were studied. Hot flushes were the most common symptom in both users and non-users and were the most frequent reason for prescribing HRT. The prevalence of menopausal symptoms in non-users of HRT was high although substantially lower than that in users. HRT users were more likely to be current cigarette smokers than were never-users. There was also, within smokers, a significant relation between the number of cigarettes smoked and the likelihood of using HRT. This relation between HRT use and smoking could result from an anti-oestrogen effect of smoking, intensifying menopausal symptoms. Of potential clinical relevance is the suggestion that a proportion of women using HRT may be doing so in order to alleviate smoking-induced symptoms. Users of HRT were also more likely to have used oral contraceptives than were never-users; this relation was probably behavioural.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3668456      PMCID: PMC1052572          DOI: 10.1136/jech.41.1.26

Source DB:  PubMed          Journal:  J Epidemiol Community Health        ISSN: 0143-005X            Impact factor:   3.710


  13 in total

1.  Noncontraceptive estrogens and nonfatal myocardial infarction.

Authors:  H Jick; B Dinan; K J Rothman
Journal:  JAMA       Date:  1978-04-03       Impact factor: 56.272

2.  Osteoporosis of the slender smoker. Vertebral compression fractures and loss of metacarpal cortex in relation to postmenopausal cigarette smoking and lack of obesity.

Authors:  H W Daniell
Journal:  Arch Intern Med       Date:  1976-03

3.  Menopausal oestrogen therapy and protection from death from ischaemic heart disease.

Authors:  R K Ross; A Paganini-Hill; T M Mack; M Arthur; B E Henderson
Journal:  Lancet       Date:  1981-04-18       Impact factor: 79.321

4.  Cigarette smoking, serum estrogens, and bone loss during hormone-replacement therapy early after menopause.

Authors:  J Jensen; C Christiansen; P Rødbro
Journal:  N Engl J Med       Date:  1985-10-17       Impact factor: 91.245

5.  Cigarette smoking and the age at menopause.

Authors:  M A Adena; H G Gallagher
Journal:  Ann Hum Biol       Date:  1982 Mar-Apr       Impact factor: 1.533

6.  Estimation of multiple relative risk functions in matched case-control studies.

Authors:  N E Breslow; N E Day; K T Halvorsen; R L Prentice; C Sabai
Journal:  Am J Epidemiol       Date:  1978-10       Impact factor: 4.897

7.  Coronary risk and estrogen use in postmenopausal women.

Authors:  R I Pfeffer; G H Whipple; T T Kurosaki; J M Chapman
Journal:  Am J Epidemiol       Date:  1978-06       Impact factor: 4.897

8.  Myocardial infarction and estrogen therapy in post-menopausal women.

Authors:  L Rosenberg; B Armstrong; H Jick
Journal:  N Engl J Med       Date:  1976-06-03       Impact factor: 91.245

9.  Obesity, hormones, and cancer.

Authors:  M A Kirschner; N Ertel; G Schneider
Journal:  Cancer Res       Date:  1981-09       Impact factor: 12.701

10.  Risk of vascular disease in women. Smoking, oral contraceptives, noncontraceptive estrogens, and other factors.

Authors:  D B Petitti; J Wingerd; F Pellegrin; S Ramcharan
Journal:  JAMA       Date:  1979-09-14       Impact factor: 56.272

View more
  6 in total

1.  Factors determining the use of hormone replacement therapy in recent naturally postmenopausal women participating in the French SU.VI.MAX cohort.

Authors:  S Mohammed-Cherif; S Briançon; G Potier de Courcy; P Preziosi; B Fieux; M Zarebska; P Galan; S Hercberg
Journal:  Eur J Epidemiol       Date:  2000-05       Impact factor: 8.082

2.  The use of hormonal replacement therapy and the risk of stroke and myocardial infarction in women.

Authors:  S G Thompson; T W Meade; G Greenberg
Journal:  J Epidemiol Community Health       Date:  1989-06       Impact factor: 3.710

3.  Hormone replacement therapy: characteristics of users and non-users in a British general practice cohort identified through computerised prescribing records.

Authors:  T Lancaster; G Surman; M Lawrence; D Mant; M Vessey; M Thorogood; P Yudkin; E Daly
Journal:  J Epidemiol Community Health       Date:  1995-08       Impact factor: 3.710

4.  Factors associated with menstrual cycle irregularity and menopause.

Authors:  Jinju Bae; Susan Park; Jin-Won Kwon
Journal:  BMC Womens Health       Date:  2018-02-06       Impact factor: 2.809

5.  Nicotine Alters Estrogen Receptor-Beta-Regulated Inflammasome Activity and Exacerbates Ischemic Brain Damage in Female Rats.

Authors:  Nathan D d'Adesky; Juan Pablo de Rivero Vaccari; Pallab Bhattacharya; Marc Schatz; Miguel A Perez-Pinzon; Helen M Bramlett; Ami P Raval
Journal:  Int J Mol Sci       Date:  2018-04-30       Impact factor: 5.923

6.  Association between cigarette smoking and the risk of dysmenorrhea: A meta-analysis of observational studies.

Authors:  Lu-Lu Qin; Zhao Hu; Atipatsa Chiwanda Kaminga; Bang-An Luo; Hui-Lan Xu; Xiang-Lin Feng; Jia-He Liu
Journal:  PLoS One       Date:  2020-04-15       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.